Current prognostic systems for myelodysplastic syndromes (MDS) are based on clinical, pathologic, and laboratory indicators. The objective of the current study was to develop a new patient-centered prognostic index for patients with advanced MDS by including self-reported fatigue severity into a well-established clinical risk classification: the International Prognostic Scoring System (IPSS).

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes / Efficace, F., Cottone, F., Abel, G., Niscola, P., Gaidano, G., Bonnetain, F., Anota, A., Caocci, G., Cronin, A., Fianchi, L., Breccia, M., Stauder, R., Platzbecker, U., Palumbo, G.A., Luppi, M., Invernizzi, R., Bergamaschi, M., Borin, L., Di Tucci, A.A., Zhang, H., et al.. - In: CANCER. - ISSN 0008-543X. - 124:6(2018), pp. 1251-1259. [10.1002/cncr.31193]

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

Luppi, Mario;
2018

Abstract

Current prognostic systems for myelodysplastic syndromes (MDS) are based on clinical, pathologic, and laboratory indicators. The objective of the current study was to develop a new patient-centered prognostic index for patients with advanced MDS by including self-reported fatigue severity into a well-established clinical risk classification: the International Prognostic Scoring System (IPSS).
2018
12-dic-2017
124
6
1251
1259
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes / Efficace, F., Cottone, F., Abel, G., Niscola, P., Gaidano, G., Bonnetain, F., Anota, A., Caocci, G., Cronin, A., Fianchi, L., Breccia, M., Stauder, R., Platzbecker, U., Palumbo, G.A., Luppi, M., Invernizzi, R., Bergamaschi, M., Borin, L., Di Tucci, A.A., Zhang, H., et al.. - In: CANCER. - ISSN 0008-543X. - 124:6(2018), pp. 1251-1259. [10.1002/cncr.31193]
Efficace, Fabio; Cottone, Francesco; Abel, Gregory; Niscola, Pasquale; Gaidano, Gianluca; Bonnetain, Franck; Anota, Amelie; Caocci, Giovanni; Cronin, ...espandi
File in questo prodotto:
File Dimensione Formato  
Efficace_et_al-2018-Cancer.pdf

Open access

Tipologia: VOR - Versione pubblicata dall'editore
Dimensione 300.75 kB
Formato Adobe PDF
300.75 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1171147
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 35
social impact